This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aronson K.J., Miller A.B., Woolcott C.G., Sterns E.E., McCready D.R., Lickley L.A., Fish E.B., Hiraki G.Y., Holloway C., Ross T., Hanna W.M., SenGupta S.K. and Weber J.P., 2000, Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk, Cancer Epidemiol. Biomarkers Prev, 9: 55-63.
Bencko V., 2003, Risk assessment and human exposure to endocrine disrupters. Molecular Epidemiology in Preventive Medicine, Jedrychowski W.A., Perera F.P., Maugeri U. (eds), International Center for Studies and Research in Biomedicine in Luxembourg, 315-27.
Bencko V., Franek P., Rames J., Fabianova E., Götzl M., 2005. Non-melanomaskin and lung cancer incidence in relation to arsenic exposure. In: RecentAdvances in Quantitative Methods in Cancer and Human Health Risk Assessment.Edler,L., Kistos,Ch.,P. Eds. John Wiley & Sons, p. 383-394.
Cantón R.F., Sanderson L.T., Bergman A. and van den Berg M.[Abstract] Effects of brominated flame retardants on activity of the steroidogenic enzyme aromatase (CYP19) in H295R human adrenocortical carcinoma cells in culture. Presented at the Dioxin conference, (Boston 2003).
Guttes S., Failing K., Neumann K., Kleinstein J., Georgii S. and Brunn H., 1998, Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease, Arch. Environ. Contam. Toxicol., 35: 140-7.
Helzlsouer K.J., Alberg A.J., Huang H.Y., Hoffman S.C., Strickland P.T., Brock J.W., Burse V.W., Needham L.L., Bell D.A., Lavigne J.A., Yager J.D. and Comstock G.W., 1999, Serum concentrations of organochlorine compounds and the subsequent development of breast cancer, Cancer Epidemiol. Biomarkers Prev,. 8: 525-32.
Kočan A., Petrik J., Jursa S., Chovancová J., Drobná B., 2001, Environmental contamination with polychlorinated biphenyls in the area of their former manufacture in Slovakia, Chemosphere, 43: 595-600.
Laden F., Ishibe N., Hankinson S.E., Wolff M.S., Gertig D.M., Hunter D.J. and Kelsey K.T. , 2002, Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study, Cancer Epidemiol. Biomarkers Prev,. 11: 1560-5.
Letcher R.J., Lemmen J.G., van der Burg B., Brouwer A., Bergman A., Giesy J.P. and van den Berg M., 2002, In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichloroethene on 17 beta- estradiol-induced gene expression in several bioassay systems, Toxicol. Sci., 69: 362-72.
Lucena R.A., Allam M.F., Costabeber I.H., Villarejo M.L. and Navajas R.F., 2001, Breast cancer risk factors: PCB congeners, Eur. J. Cancer Prev,. 10: 117-9.
Moore M., Mustain M., Daniel K., Chen I., Safe S., Zacharewski T., Gillesby B., Joyeux A. and Balaguer, P., 1997, Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum, Toxicol. Appl. Pharmacol,. 142: 160-8.
Pavúk M., Cerhan J.R., Lynch C.F., Schecter A., Petrik J., Chovancova J., Kocan, A., 2004, Environmental exposure to PCBs and cancer incidence in eastern Slovakia., Chemosphere, 54(10): 1509-20.
Safe S.H., 1994., Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment, Critical Reviews in Toxicology, 24: 87-149.
Safe S., Wang F., Porter W., Duan R. and McDougal A., 1998, Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms, Toxicol. Lett., 102-103: 343-7.
Safe, S., Wormke, M. et al., 2000, Mechanisms of inhibitory aryl hydrocarbon receptor- estrogen receptor crosstalk in human breast cancer cells, J. Mammary Gland. Biol. Neoplasia, 5(3): 295-306.
Trnovec T., Bencko V., Langer P., van den Berg M., Kočan A., Bergman A., Machala M., Hustak M., 2004, PCBRISK Project Slovakia: Study design, objectives, hypotheses, main findings, health consequences for the population exposed, rationale of future research, Dioxins 2004, Berlin, Organohalogen Compounds 66, 2004, 3573-3579.
van den Berg M., Birnbaum L., Bosveld B.T.C., Brunstrom B., Cook P., Feely M. and Giesy J.P., 1998, Toxic equivalency factors (TEFs) for PCBs, PCDDs and PCDFs for humans and wildlife, Environ. Health Perspect,. 106: 775-792.
Wolff M.S., Zeleniuch-Jacquotte A., Dubin N. and Toniolo P., 2000, Risk of breast cancer and organochlorine exposure, Cancer Epidemiol. Biomarkers Prev., 9: 271-7.
Zheng T., Holford T.R., Tessari J., Mayne S.T., Owens P.H., Ward B., Carter D., Boyle P., Dubrow R., Archibeque-Engle S. and Zahm, S. H., 2000, Breast cancer risk associated with congeners of polychlorinated biphenyls, Am. J. Epidemiol., 152: 50-8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this paper
Cite this paper
Bencko, V., Rameš, J., Van Den Berg, M., Pleško, I., Trnovec, T. (2006). Human Exposure To Polyhalogenated Hydrocarbons and Incidence of Selected Malignancies. In: Donnelly, K.C., Cizmas, L.H. (eds) Environmental Health in Central and Eastern Europe. Springer, Dordrecht. https://doi.org/10.1007/1-4020-4845-9_4
Download citation
DOI: https://doi.org/10.1007/1-4020-4845-9_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-4844-9
Online ISBN: 978-1-4020-4845-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)